This podcast interviews Dr. Scott Sherr about hyperbaric oxygen therapy (HBOT) and methylene blue, focusing on their uses for health optimization and mitochondrial support. The host and guest discuss HBOT's mechanism, potential downsides (oxidative stress), and the importance of pre-existing health for optimal results; methylene blue's role in mitochondrial function, its various uses (including as an infection treatment), and potential risks are also explored. Specific examples include the cost range of home HBOT chambers ($8,000-$250,000) and the importance of slow dose escalation with methylene blue to avoid side effects. Listeners gain insights into these therapies and the holistic approach needed for effective use, including lifestyle adjustments and nutritional considerations.
